Latest Meningococcal disease Stories
With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide BASEL, Switzerland, Jan.
FORT MYERS, Fla., Jan. 23, 2015 /PRNewswire/ -- Today the U.S.
ATLANTA, Oct. 29, 2014 /PRNewswire/ -- The U.S.
ATLANTA, Sept. 19, 2014 /PRNewswire/ -- This week, a student at Georgetown University died from serogroup B meningococcal disease.
Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination SWIFTWATER, Pa., Sept.
Investigators at the University of Southampton have discovered that two new vaccines can prevent the transmission of meningitis bacteria from person to person.
Submission follows receipt of Breakthrough Therapy designation in April 2014, highlighting unmet need for a licensed vaccine for serogroup B in the US(1) BASEL, Switzerland, June 17, 2014 /PRNewswire/
Transparency Market Research published a new report "Meningococcal Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
Report Identifies Challenges and Includes Recommendations for Management of Future Meningococcal Disease Outbreaks Bethesda, Maryland (PRWEB) May 22, 2014
DUBLIN, May 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rd8s6p/meningococcal)
Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...
- The word or words serving to define another word or expression, as in a dictionary entry.